期刊文献+

卡维地洛微孔渗透泵颗粒的制备及其性能 被引量:4

Study on preparation and properties of the microbore osmotic pump granules loaded carvedilol
原文传递
导出
摘要 目的:制备卡维地洛微孔渗透泵颗粒,并对其性能进行研究。方法:以卡维地洛作为模型药物,以氯化钠为渗透压活性物质,酒石酸为溶解度调节剂,醋酸纤维素为包衣膜材,PEG400为水溶性致孔剂,采用正交试验设计法L9(34)优选卡维地洛微孔渗透泵颗粒制备工艺。结果:卡维地洛微孔渗透泵颗粒在模拟胃肠环境中按零级动力学方式释放药物,具有明显的渗透泵特征和控释效果,且基本不受胃肠pH环境的影响,12 h内累积释放度可达71.90%。结论:卡维地洛微孔渗透泵颗粒处方组成合理、制备工艺可行,可望成为一种新的卡维地洛控释剂型。 OBJECTIVE To prepare carvedilol microbore porosity osmotic pump granules, and study its properties. METHODS Using carvedilol as a model drug, NaCl as the osmotic active agent, tartaric acid as the solubility regulator, cellulose acetate as the coating materials, and PEG 400 as the water-soluble pore-forming agent, the carvedilol microbore osmotic pump granules technology were optimized by orthogonal design of L9 (34 ). Also, its some properties were studied. RESULTS The deliveries of carvedilol microbore osmotic pump granules was found to accord with a zero order rate in the simulated gastro-in- testinal tract environments, and no significant difference existed in the two kinds of pH conditions, the accumulated release achieved to 71.90% within 12 h. The carvedilol microbore osmotic pump granules possessed obviously osmotic pump feature and controlled release effect in vitro. CONCLUSION The preparing compositions of the carvedilol microbore osmotic pump granules were reasonable, and the preparation can be carried out. The carvedilol microbore osmotic pump granules have the potential to be a novel controlled release dosage form.
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2012年第10期769-772,共4页 Chinese Journal of Hospital Pharmacy
基金 兰州大学第二医院医学研究基金(编号:YJ2010-08) 兰州大学交叉学科青年创新研究基金(编号:LZUJC200929)
关键词 卡维地洛 微孔渗透泵 颗粒 制备 性能 carvedilol microbore osmotic pump granules preparation property
  • 相关文献

参考文献9

二级参考文献32

共引文献48

同被引文献54

  • 1陈晓昱,张志荣,任科,龚涛.辣椒碱-羟丙基-β-环糊精包合物制备鉴定及热力学稳定性研究[J].中国中药杂志,2009,34(4):394-397. 被引量:12
  • 2颜廷旭,杨星钢,程洁,王启明,潘卫三.四逆散双层渗透泵控释片片芯单因素考察[J].中国药剂学杂志(网络版),2010(2):64-73. 被引量:6
  • 3赵学玲,李强,龚显峰,李三鸣.微孔渗透泵片的药物传递机制[J].药学学报,2007,42(2):226-229. 被引量:18
  • 4中国药典一部[S].2010年:32. 被引量:955
  • 5Dwarakanadha Reddy P, Swarnalatha D. Recent advanc- es in novel drug delivery systems[J]. International Jour- nal ofPharm Tech Research, 2010,2 (3) : 2 025. 被引量:1
  • 6Wei L, Li J, Guo L, et al. Investigation s of a novel self- emulsifying osmotic pump tablet containing carvedilol[J]. Drug Dev Ind Pharm, 2007,33 (9) : 990. 被引量:1
  • 7Philip AK, Pathak K, Shakya P. Asymmetric membrane in membrane capsules: a means for achieving delayed and osmotic flow of cefadroxil[J]. Eur J Pharm Bio- pharm, 2008,69 (2) : 658. 被引量:1
  • 8Philip AK, Pathak K. Wet process induced phase transited drug delivery system: a means for achieving osmotic, controlled, and level a ivivc for poorly water soluble drug [J]. Drug Dev Ind Pharm, 2008,34 (7) : 735. 被引量:1
  • 9Chauhan CS, Choudhury PK. Controlled porosity osmotic pump for the delivery of flurbiprofen[J]. Curr Drug Deliv, 2006,3(2):193. 被引量:1
  • 10Choudhury PK, Chauhan CS, Ranawat MS. Osmotic de- livery of flurbiprofen through controlled porosity asym- metric membrane capsule[J]. Drug Dev Ind Pharm, 2007, 33(10):1 135. 被引量:1

引证文献4

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部